Esomeprazole Magnesium Capsule, Delayed Release Pellets
Product Images NDC 68462-390

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 68462-390). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure2.jpg (Figure2)

A line graph showing percent of patients maintained over six months for Esomeprazole Magnesium at 40 mg, 20 mg, and 10 mg doses compared to placebo. The x-axis represents months (0 to 6), and the y-axis represents percent maintained (0 to 100%). The 40 mg dose maintains the highest percent, followed by 20 mg, then 10 mg, with placebo showing the lowest maintenance over time.*

FDA Label Image

Figure3.jpg (Figure3)

A Kaplan-Meier curve chart showing the percentage of patients maintaining response over six months for Esomeprazole Magnesium at 10 mg, 20 mg, and 40 mg doses compared to placebo. The x-axis represents months from 0 to 6, and the y-axis shows percent maintained from 0 to 100%. Esomeprazole Magnesium at all doses shows higher maintenance rates compared to placebo over time.*

FDA Label Image

Figure4.jpg (Figure4)

A line graph depicting the percent of patients symptom-free over 28 diary days for three groups: Esomeprazole Magnesium 40 mg, Esomeprazole Magnesium 20 mg, and placebo. The y-axis shows the percent symptom-free from 0 to 100, and the x-axis shows diary days from 0 to 28. The graph indicates symptom improvement trends over the study period for each treatment group.*

FDA Label Image

Figure5.jpg (Figure5)

A line graph showing the percentage of patients symptom-free over diary days up to 28 days. It compares three groups: Esomeprazole Magnesium 40 mg, 20 mg, and placebo, indicating higher symptom-free percentages for both Esomeprazole Magnesium doses compared to placebo over time.*

FDA Label Image

Lbl20mg30.jpg (Lbl20mg30)

Label for Esomeprazole Magnesium Delayed-Release Capsules, USP 20 mg, oral capsules containing delayed-release pellets. The label indicates the product is supplied by Glenmark Pharmaceuticals Inc., USA, with a package size of 30 capsules. It includes storage instructions, dosage guidance, and pharmacist dispensing information.*

FDA Label Image

Lbl40mg30.jpg (Lbl40mg30)

Label for Esomeprazole Magnesium Delayed-Release Capsules USP 40 mg by Glenmark Pharmaceuticals Inc., USA. The label indicates the product contains 30 capsules and is for prescription use only. Storage and usage instructions are provided along with a pharmacist dispensing note.*

FDA Label Image

Image 01

FDA Label Image

Logo

FDA Label Image

Structure (Structure)

Chemical structure of Esomeprazole Magnesium, showing the molecular arrangement including methoxy groups, sulfur atom, and magnesium ion with hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.